@article{cdae6b4e0b2242508366d847730535f2,
title = "IVUS guidance during left main PCI: Not if, but when and how",
author = "Akiko Maehara and Mintz, {Gary S.} and Stone, {Gregg W.}",
note = "Funding Information: A. Maehara reports research grant and consultant fees from Boston Scientific and Abbott Vascular. G. Mintz reports speaker honoraria from Terumo, Philips, Boston Scientific and Medtronic. G. Stone reports speaker or other honoraria from Cook, Terumo, Qool Therapeutics and Orchestra Biomed; he is a consultant to Valfix, TherOx, Vascular Dynamics, Robocath, HeartFlow, Gore, Ablative Solutions, Miracor, Neovasc, V-Wave, Abiomed, Ancora, MAIA Pharmaceuticals, Vectorious, Reva and Matrizyme; and holds equity/options from Ancora, Qool Therapeutics, Cagent, Applied Therapeutics, Biostar family of funds, SpectraWave, Orchestra Biomed, Aria, Cardiac Success, MedFocus family of funds and Valfix.",
year = "2020",
month = jun,
doi = "10.4244/EIJV16I3A32",
language = "English",
volume = "16",
pages = "189--191",
journal = "EuroIntervention",
issn = "1774-024X",
publisher = "EuroPCR",
number = "3",
}